Abiraterone Hydrochloride is a potent antiandrogenic agent classified as a CYP17 inhibitor, used clinically in the management of metastatic prostate cancer by inhibiting testosterone biosynthesis. This… Read more
Abiraterone Hydrochloride is a potent antiandrogenic agent classified as a CYP17 inhibitor, used clinically in the management of metastatic prostate cancer by inhibiting testosterone biosynthesis. This category provides access to high-quality reference standards for Abiraterone Hydrochloride and its associated impurities, including related process-related compounds such as (10R,13S)-10,13-dimethyl-17-(pyridin-3-yl)-dodecahydrocyclopenta[a]phenanthren-3-one hydrobromide. Pharmaceutical and research laboratories utilize these certified reference materials for comprehensive impurity profiling, method validation, and rigorous quality control protocols. Furthermore, the inclusion of stable isotope labelled compounds facilitates precise quantitative analysis through mass spectrometry, ensuring accurate identification and measurement of drug-related substances in complex matrices. By maintaining a robust selection of these analytical standards, researchers can effectively characterize degradation pathways and monitor the purity profile of pharmaceutical formulations throughout the drug development lifecycle.